MAMalak Alrubaie

Malak Alrubaie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Malak Alrubaie has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    National HTA system in Canada: From system analysis and understanding to system strengthening

    by Mohammed Alkhaldi, Rima Kachach, Aisha Al Basuoni, Line Enjalbert, Malak Alrubaie, Maya Hassan, Sara Ahmed

    Health Technology Assessment (HTA) has played a critical role in guiding evidence-based decision-making in Canada’s healthcare system; however, its current structure and processes face several limitations that reduce its effectiveness and responsiveness. To effectively address these challenges, there is a clear need for a comprehensive framework that outlines the key components of Canada’s HTA system—including its conceptual foundations, policy environment, structural organization, governance models, institutional capacities, implementation pathways, and integration into decision-making processes. Such a framework would support more coordinated, transparent, and responsive HTA practices across jurisdictions. Using a systems thinking and analytical approach, the study aims to comprehensively analyze the components of the national HTA system in Canada. The study was conducted between 3 rd May 2021 and 22 nd April 2022, selectively recruiting experts and organizations involved in HTA. Seven national HTA experts participated in virtual In-Depth Interviews (IDIs) to understand HTA from a policy perspective, and ten HTA-associated organizations from the Canadian governmental and non-governmental sectors completed one electronic institutional survey to understand HTA from a technical perspective. Findings indicate a high level of literacy/understanding and perceived applicability of HTA, though challenges exist in governance, legislation, and decentralized coordination. While there’s general support for HTA, concerns arise regarding the extent of HTA report utilization and the need for a more cohesive national HTA approach. Capacity-wise, sustainable funding exists, but challenges include varying assessment coverage and the lack of harmonized guidelines resulting from a decentralized structure revealed within provinces. Qualitative findings revealed a decentralized structure with provincial-level HTA bodies, limited national coordination, and inconsistent integration into decision-making. Experts emphasized the need for standardized guidelines, improved capacity, and stronger national oversight to enhance the utilization of HTA. This study proposes advancing national coordination and developing standardized HTA guidelines to address fragmentation. It also recommends investing in capacity-building, training, and sustainable funding to strengthen HTA implementation. In conclusion, this study generates evidence of the strengths of the Canadian HTA system, as well as the presence of significant legislative, structural, policy, and capacity-related challenges. Despite the available funding, human resources, and capacity, and the active role of the Canadian Agency for Drugs and Technologies in Health (CADTH), establishing national HTA frameworks and strategies is a priority. This strategy, along with reinforcing provincial and federal stakeholder engagement, improving adoption pathways of HTA recommendations, and adapting HTA methodologies for more flexible and timely evaluations, can strengthen the Canadian HTA system.

  • Open Access

    Health technology assessment system in Switzerland: Current state, gaps, and prospects for improvement

    by Mohammed Alkhaldi, Rima Kachach, Line Enjalbert, Aisha Al Basuoni, Malak Alrubaie, Sara Ahmed

    Switzerland maintains a distinct HTA system that often aligns with EU requirements and reflects its unique healthcare governance model, with structured processes led by the Federal Office of Public Health (FOPH), despite lacking a comprehensive national framework. These processes, though sometimes limited in scope, produce nationally binding decisions. This study aims to comprehensively analyze and understand the key pillars of the national HTA system, identify obstacles, and propose insights to strengthen the HTA system in Switzerland. This system analysis study was conducted between 2021 and 2023, targeting key Swiss HTA-associated organizations and experts from various health sectors. Mixed methods were used to gather data using electronic institutional surveys completed by nine organizations to assess HTA technical aspects and virtual in-depth interviews (IDIs) with eight experts to understand HTA from a policy perspective. The study examined HTA practices in the Swiss organizations, comprising 67% academic, 22% public, and 11% non-governmental sectors. Findings revealed that 67% of the organizations mentioned that structured processes were led by the FOPH as the central agency (67%). While 56% (n = 5) of organizations reported substantial funding, challenges included a lack of government funding. In Switzerland, HTAs most frequently addressed safety, clinical effectiveness, and economic aspects, while social acceptability and feasibility were less commonly considered. Strong interest in expanding HTA capacity was expressed. However, there is limited awareness and advocacy for HTA, insufficient political support, limited institutional capacity, and persistent gaps in funding. The study highlights the importance of HTA in healthcare decision-making and resource allocation in Switzerland, and the need for addressing the integration gap of HTA into decision-making. Enhancing awareness and institutional strengthening are key to advancing HTA. This study offers insights to guide future research and to establish a national HTA agency, to improve integration and coordination of HTA across all Swiss Cantons.